In vitro, the PD-1 attachment increases T-cell activation (3.3-fold elevation of interferon-γ) and leads to efficient and highly selective cytotoxicity against CD33+PD-L1+ cell lines and patient-derived AML cells (n = 8). This evidence concerns the gene CD274 and acute myeloid leukemia.